Wczytywanie spółki
Just reported
Q3 2026 results
From Tenet Healthcare's results release of 29 października 2026; its quarterly report has since been filed.
Revenue
Actual
5,63B USD
+6,5% y/y
+0,1% q/qGuided
—
No guide given
EPS, GAAP
Actual
12,41 USD
+222% y/y
+26% q/qGuided
—
No guide given
Operating income, GAAP
Actual
1,75B USD
+97% y/y
+17% q/qGuided
—
No guide given
Company outlook
Full year 2026
- Revenue22,05B USD – 22,45B USD+4,4% y/y Unchanged
- EPS, adjusted22,05 USD – 23,01 USDRaised +7,3%
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Tenet Healthcare is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The theme it is part of
Highest-graded in Medical Care Facilities
Graded A or B and worth $2B or more: A first, then the largest.
EHCEncompass Health Corporation13,8B USDA+
ENSGEnsign Group, Inc.10,9B USDA
PACSPACS Group, Inc.7,6B USDA
CONConcentra Group Holdings Parent, Inc.5,4B USDA
LFSTLifeStance Health Group, Inc.5,4B USDA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 paź 2026CBGraded C, now B
MCKMckesson Corporation4 lis 2026BAGraded B, now A
CVSCVS Health Corp4 lis 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 lis 2026BAGraded B, now A
BIIBBiogen Inc.28 paź 2026BAGraded B, now A
Pełne sprawozdania finansowe →
Zbudowane z własnych raportów spółki Tenet Healthcare Corp. składanych do amerykańskiej Komisji Papierów Wartościowych i Giełd (SEC). Liczby są takie, jak zaraportowano, a historia na akcję przeliczona na dzisiejszą bazę akcji. To opisuje firmę — nie jest poradą inwestycyjną ani rekomendacją kupna lub sprzedaży.
